Plasma secretory leukocyte protease inhibitor in febrile patients

Clinical Microbiology and Infection

Volumn 9, Issue 7, 2003, Pages 605-613

  Duits, L A ^a   Tjabringa, G S ^a   Aarts, N J M ^b   van't Wout, J W ^b   Hiemstra, P S ^a   Nibbering, P H ^a   van Dissel, Jaap T ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

Respiratory tract infection; Secretory leukocyte protease inhibitor

Indexed keywords

INTERLEUKIN 10; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BACTEREMIA; BLOOD ANALYSIS; BLOOD PRESSURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HEART RATE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN TISSUE; LEUKOCYTE; LUNG INFECTION; LUNG INFILTRATE; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MEDIATOR; MEDICAL PARAMETERS; MULTIVARIATE ANALYSIS; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PYELONEPHRITIS; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT MUCOSA; SCORING SYSTEM; THORAX RADIOGRAPHY;

EID: 0042026558     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2003.00582.x     Document Type: Article

References (29)

1. Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 1996; 125: 680-7.
2. Hurley JC. Reappraisal with meta-analysis of bacteremia, endotoxemia and mortality in Gram-negative sepsis. J Clin Microbiol 1995; 33: 1278-82.
3. Timmerman CP, Mattson E, Martinez-Martinez L et al. Induction of release of tumour necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycan. Infect Immun 1993; 61: 4167-72.
4. Langevelde P, van Dissel JT, Ravensbergen E, Appelmelk BJ, Schrijver IA, Groeneveld PHP. Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus. Quantitative measurements and biological activity. Antimicrob Agents Chemother 1998; 42: 3073-8.
5. Bossink AWJ, Groeneveld ABJ, Thijs LG. Prediction of microbial infection and mortality in medical patients with fever. plasma procalcitonin, neutrophilic elastase-a1-antitrypsin, and lactoferrin compared with clinical variables. Clin Infect Dis 1999; 29: 398-407.
6. Van Dissel JT, Van Langevelde P, Westendorp RGJ, Kwappenberg K, Frölich M. An anti-inflammatory cytokine profile is associated with mortality in febrile patients admitted to the hospital. Lancet 1998; 351: 950-3.
7. Hamilton G, Hofbauer S, Hamilton B. Endotoxin, TNF, interleukin-6 and parameters of the cellular immune system in patients with abdominal sepsis. Scand J Infect Dis 1992; 24: 361-8.
8. Opal SM, Cohen J. Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? Crit Care Med 1999; 27: 1608-16.
9. Cohen J, Abraham E. Microbiologic findings and correlations with serum tumor necrosis factor-alpha in patients with severe sepsis and septic shock. J Infect Dis 1999; 180: 116-21.
10. Goldman JM, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM. Human β-defensin-1 is a salt sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 1997; 88: 553-60.
11. Hiemstra PS, Maassen RJ, Stolk J, Heinzel-Wieland R, Steffens GJ, Dijkman JH. Antimicrobial activity of antileukoprotease. Infect Immun 1996; 64: 4520-4.
12. Tomee JFC, Hiemstra PS, Heinzel-Wieland R, Kauffman HF. Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi. J Infect Dis 1997; 176: 740-7.
13. McNeely TB, Dealy M, Dripps DJ, Orenstein JM, Eisenberg SP, Waffi SM. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest 1995; 96: 456-64.
14. Ohlsson K, Bergenfeldt M, Bjork P. Functional studies of human secretory leukocyte protease inhibitor. Adv Exp Med Biol 1988; 240: 123-31.
15. Rice WO, Weiss SJ. Regulation of proteolysis at the neutrophil-substrate interface by secretory leukocyte inhibitor. Science 1990; 249: 178-81.
16. Amitani R, Wilson R, Rutman A et al. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. Am J Resp Cell Mol Biol 1991; 4: 26-32.
17. Mainardi C, Dixit SN, Rang AH. Degranulation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules. J Biol Chem 1980; 255: 5435-41.
18. Brown DM, Brown OM, MacNee W, Donaldson K. Activated human peripheral blood neutrophils produce epithelial injury and fibronectin breakdown in vitro. Inflammation 1992; 16: 21-30.
19. Sano C, Shimizu T, Sato K, Kawauchi H, Tomioka H. Effects of secretory leukocyte protease inhibitor on the production of the anti-inflammatory cytokines IL-10 and transforming growth factor-beta (TGF-β) by lipopolysaccharide-stimulated macrophages. Clin Exp Immunol 2000; 121: 77-85.
20. Jin FY, Nathan CF, Radzioch D, Ding A. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 1997; 88: 417-6.
21. Gompertz S, Bayley DL, Hill SL, Stockley RA. Relation between airway inflammation and the frequency of e xacerbations in patients with smoking related COPD. Thorax 2001; 56: 36-41.
22. Grobmyer SR, Bane PS, Nathan CF et al. Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia. Crit Care Med 2000; 28: 1276-82.
23. McCabe WR, Jackson GG. Gram-negative bacteremia, I. etiology and ecology. Arch Intern Med 1962; 110: 847-53.
24. Wingens M, van Bergen BH, Hiemstra PS et al. Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes. J Invest Dermatol 1998; 111: 996-1002.
25. Saitoh H, Masuda T, Shimura S, Fushimi T, Shirato K. Secretion and gene expression of secretory leukocyte protease inhibitor by human airway submucosal glands. Am J Physiol 2001; 280: L79-L87.
26. Andoh Y, Shimura S, Saitoh H, Sasaki T, Mitsuhashi H, Shirato K. Serum secretory leukoprotease inhibitor levels in chronic bronchitis and Sjogren's syndrome. Tohoku J Exp Med 1997; 182: 319-25.
27. Kida K, Mizuuchi T, Takeyama K et al. Serum secretory leukocyte inhibitor levels to diagnose pneumonia in the eldery. Am Rev Respir Dis 1992; 146: 1426-9.
28. Sallenave J-M, Shulmann J, Crossley J, Jordana M, Gauldie J. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/Elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am J Respir Cell Mol Biol 1994; 11: 733-41.
29. Franken C, Meijer CJLM, Dijkman JH. Tissue distribution of antileukoprotease and lysozyme in humans. J Histochem Cytochem 1989; 37: 493-8.